GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Yonghe Medical Group Co Ltd (HKSE:02279) » Definitions » Beneish M-Score

Yonghe Medical Group Co (HKSE:02279) Beneish M-Score : 1.82 (As of Apr. 16, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Yonghe Medical Group Co Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score 1.82 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for Yonghe Medical Group Co's Beneish M-Score or its related term are showing as below:

HKSE:02279' s Beneish M-Score Range Over the Past 10 Years
Min: -3.1   Med: -2.65   Max: 1.82
Current: 1.82

During the past 7 years, the highest Beneish M-Score of Yonghe Medical Group Co was 1.82. The lowest was -3.10. And the median was -2.65.


Yonghe Medical Group Co Beneish M-Score Historical Data

The historical data trend for Yonghe Medical Group Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yonghe Medical Group Co Beneish M-Score Chart

Yonghe Medical Group Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Beneish M-Score
Get a 7-Day Free Trial -3.10 -2.65 -2.45 -3.01 1.82

Yonghe Medical Group Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.45 - -3.01 - 1.82

Competitive Comparison of Yonghe Medical Group Co's Beneish M-Score

For the Medical Care Facilities subindustry, Yonghe Medical Group Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Yonghe Medical Group Co's Beneish M-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Yonghe Medical Group Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Yonghe Medical Group Co's Beneish M-Score falls into.


;
;

Yonghe Medical Group Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Yonghe Medical Group Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 5.5964+0.528 * 0.9338+0.404 * 1.5622+0.892 * 0.9911+0.115 * 10.8432
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.1361+4.679 * -0.263564-0.327 * 0.9585
=1.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec24) TTM:Last Year (Dec23) TTM:
Total Receivables was HK$103 Mil.
Revenue was HK$1,927 Mil.
Gross Profit was HK$1,158 Mil.
Total Current Assets was HK$672 Mil.
Total Assets was HK$1,843 Mil.
Property, Plant and Equipment(Net PPE) was HK$1,000 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$17 Mil.
Selling, General, & Admin. Expense(SGA) was HK$1,026 Mil.
Total Current Liabilities was HK$583 Mil.
Long-Term Debt & Capital Lease Obligation was HK$498 Mil.
Net Income was HK$-242 Mil.
Gross Profit was HK$0 Mil.
Cash Flow from Operations was HK$244 Mil.
Total Receivables was HK$19 Mil.
Revenue was HK$1,944 Mil.
Gross Profit was HK$1,091 Mil.
Total Current Assets was HK$885 Mil.
Total Assets was HK$2,674 Mil.
Property, Plant and Equipment(Net PPE) was HK$1,630 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$366 Mil.
Selling, General, & Admin. Expense(SGA) was HK$911 Mil.
Total Current Liabilities was HK$791 Mil.
Long-Term Debt & Capital Lease Obligation was HK$845 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(102.807 / 1926.612) / (18.536 / 1943.927)
=0.053362 / 0.009535
=5.5964

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(1090.701 / 1943.927) / (1157.583 / 1926.612)
=0.561081 / 0.600839
=0.9338

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (672.436 + 999.912) / 1842.994) / (1 - (885.224 + 1630.102) / 2673.809)
=0.092592 / 0.059272
=1.5622

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=1926.612 / 1943.927
=0.9911

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(366.241 / (366.241 + 1630.102)) / (17.209 / (17.209 + 999.912))
=0.183456 / 0.016919
=10.8432

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(1026.101 / 1926.612) / (911.333 / 1943.927)
=0.532593 / 0.46881
=1.1361

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((498.102 + 582.641) / 1842.994) / ((845.155 + 790.694) / 2673.809)
=0.586406 / 0.611805
=0.9585

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-241.66 - 0 - 244.086) / 1842.994
=-0.263564

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Yonghe Medical Group Co has a M-score of 1.82 signals that the company is likely to be a manipulator.


Yonghe Medical Group Co Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Yonghe Medical Group Co's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Yonghe Medical Group Co Business Description

Traded in Other Exchanges
N/A
Address
11th Floor, 20 Ganluyuan Nanli, China Nuclear E&C Building, Chaoyang District, Beijing, CHN, 100020
Yonghe Medical Group Co Ltd is a medical group in China that specializes in providing hair-related healthcare services. It is principally engaged in the provision of hair transplant services which are subject to similar types of services, similar classes of customers, similar regulatory environment, and similar business risk. The company generated the majority of the revenue from hair transplant services. It offers one-stop hair-related healthcare services covering hair transplants, medical hair care, routine hair restoration, and other ancillary services.
Executives
Zhang Yu 2307 Founder of a discretionary trust who can infl
Cyh Cosmetic Medical Investment Limited
Pan Mao Shang Hai Tou Zi Zhong Xin You Xian He Huo
Shang Hai Pan Nuo Qi Ye Guan Li Fu Wu You Xian Gong Si
Zhong Xin Chan Ye Tou Zi Ji Jin Guan Li You Xian Gong Si
Zy Ventures Ltd
Zy Investment Capital Ltd
Yonghe Hair Service Holdings Limited
Cyh Cosmetic Medical Holdings Limited
Cpechina Fund Iia, L.p.
Cpechina Fund Ii, L.p.
Citron Pe Holdings Limited
Citron Pe Funds Ii Limited
Citron Pe Associates Ii, L.p.
Citic Securities Company Limited

Yonghe Medical Group Co Headlines

No Headlines